Get the Stockscreener App
5.71
0.96%
-0.04
Inogen Inc stock is traded at $5.71, with a volume of 188.48K.
It is down -0.96% in the last 24 hours and down -13.32% over the past month.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
See More
Previous Close:
$5.75
Open:
$5.71
24h Volume:
188.48K
Relative Volume:
0.67
Market Cap:
$151.53M
Revenue:
$351.50M
Net Income/Loss:
$-24.90M
P/E Ratio:
-6.2309
EPS:
-0.9164
Net Cash Flow:
$-10.24M
1W Performance:
-5.40%
1M Performance:
-13.32%
6M Performance:
+0.08%
1Y Performance:
-23.66%
1-Day Range:
$5.63
$5.81
1-Week Range:
$5.63
$6.278
52-Week Range:
$5.3401
$9.13
Inogen Inc Stock (INGN) Company Profile
Name
Inogen Inc
Sector
Industry
Phone
805-562-0500
Address
500 CUMMINGS CENTER, BEVERLY, CA
Compare INGN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
5.71 | 152.60M | 351.50M | -24.90M | -10.24M | -0.9164 |
ABT
Abbott Laboratories
|
110.11 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
332.33 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.64 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.55 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.80 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-25 | Initiated | B. Riley Securities | Buy |
| May-22-25 | Upgrade | Needham | Hold → Buy |
| Feb-15-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Aug-08-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-14-23 | Downgrade | Needham | Buy → Hold |
| Jan-17-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-09-21 | Upgrade | Needham | Hold → Buy |
| Nov-02-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-05-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-04-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-14-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-20 | Downgrade | Needham | Buy → Hold |
| May-06-20 | Reiterated | Needham | Buy |
| Nov-06-19 | Upgrade | Needham | Hold → Buy |
| Sep-13-19 | Reiterated | Piper Jaffray | Overweight |
| Aug-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Aug-08-19 | Downgrade | Stifel | Buy → Hold |
| Aug-07-19 | Downgrade | Needham | Buy → Hold |
| Jun-28-19 | Downgrade | Needham | Strong Buy → Buy |
| May-08-19 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-19 | Reiterated | Needham | Strong Buy |
| Feb-27-19 | Reiterated | Needham | Strong Buy |
| Nov-20-18 | Upgrade | Needham | Buy → Strong Buy |
| Nov-07-18 | Reiterated | Needham | Buy |
| Sep-10-18 | Downgrade | Needham | Strong Buy → Buy |
| Aug-22-18 | Resumed | Stifel | Buy |
| Aug-08-18 | Reiterated | Needham | Strong Buy |
| Jun-06-18 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| May-01-18 | Reiterated | Needham | Strong Buy |
| Feb-28-18 | Reiterated | Needham | Strong Buy |
View All
Inogen Inc Stock (INGN) Latest News
Dimensional Fund Advisors LP Reduces Position in Inogen, Inc $INGN - MarketBeat
Inogen Inc. Earnings Call Balances Growth and Caution - TipRanks
Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists - Yahoo Finance
Should Investors Buy Inogen as Low Valuation Meets Execution Risk? - Yahoo Finance
Inogen Launches First CPAP Mask Portfolio - respiratory-therapy.com
Inogen Launches Voxi 5 Stationary Oxygen Concentrator - respiratory-therapy.com
Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut - Yahoo Finance Singapore
Inogen, Inc. (NASDAQ:INGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$12.67 - Sahm
Inogen (NASDAQ:INGN) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Inogen (INGN) Has a New Rating from B. Riley Securities - The Globe and Mail
Inogen Inc (6IO.SG) Analyst insights, Price targets and Recommendations - Yahoo Finance Australia
Q2 2026 Inogen, Inc. Earnings Call Transcript - GuruFocus
Inogen Q2 2026 slides: international growth offsets U.S. weakness By Investing.com - Investing.com South Africa
Inogen Inc Q2 2026: Revenue $95.08M, EPS $(0.14) — 10-Q Summary - TradingView
Inogen (NASDAQ: INGN) posts Q2 2026 revenue growth but stays unprofitable - Stock Titan
Inogen, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Inogen Q2 Earnings Call Highlights - sharewise.com
Inogen Inc (INGN) (Q2 2026) Earnings Call Highlights: Strong Int - GuruFocus
Inogen, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:INGN) 2026-08-06 - Seeking Alpha
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Is Inogen Inc (INGN) Undervalued After Q2 Earnings Miss? EPS at -$0.15, Revenue at $95.1M, GF Score: 66/100 - GuruFocus
Inogen Inc earnings beat by $0.03, revenue topped estimates - Investing.com
Inogen, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Inogen (NASDAQ:INGN) Falls as Revenue Misses and Full-Year Guidance Trails Estimates - ChartMill
Inogen, Inc. Revises Earnings Guidance for Full Year 2026 - marketscreener.com
Inogen: Q2 Earnings Snapshot - marketscreener.com
Inogen posts Q2 2026 revenue $95.1M, raises full-year adjusted EBITDA guidance to ~$4.0M - TradingView
Tranche Update on Inogen, Inc.'s Equity Buyback Plan announced on February 24, 2026. - marketscreener.com
Inogen, Inc. Provides Earnings Guidance for the Third Quarter of 2026 - marketscreener.com
Inogen, Inc. expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Arrowstreet Capital Limited Partnership Acquires 393,310 Shares of Inogen, Inc $INGN - MarketBeat
Inogen (NASDAQ:INGN) Stock Crosses Below 200-Day Moving AverageHere's What Happened - MarketBeat
Inogen, Inc Revenue Breakdown – NASDAQ:INGN - TradingView
Inogen Inc (INGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Inogen Inc (INGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Inogen Inc (INGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inogen Inc (INGN) Institutional Confidence - TradingKey
Inogen Inc (INGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Inogen Inc (INGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Inogen Inc (INGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
INGN|Inogen Inc|Price:6.150|Chg%:-0.170 - TradingKey
Inogen Inc (INGN) Balance Sheet - TradingKey
TradingKey - TradingKey
Inogen Inc (INGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Inogen Inc Q1 2026 Earnings: EPS Miss Weighs on Sentiment, Stock Edges HigherPretax Income Report - dars.gov.et
Inogen stock trades quietly as investors weigh margin pressure and restructuring impact - Ad-hoc-news.de
Inogen to report Q2 2026 results after market close, host conference call - Bitget
Inogen to report second quarter 2026 results on August 6 - scanx.trade
Press Release: Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026 - Moomoo
Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026 - Business Wire
Inogen Inc (INGN) Holds Steady Near Support as Consolidation ContinuesMFI Divergence - dars.gov.et
Inogen Inc Stock (INGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):